Literature DB >> 33469230

TEAD1 protects against necroptosis in postmitotic cardiomyocytes through regulation of nuclear DNA-encoded mitochondrial genes.

Jinhua Liu1,2, Tong Wen2,3,4, Kunzhe Dong2, Xiangqin He2, Hongyi Zhou5, Jian Shen2,6, Zurong Fu6, Guoqing Hu2, Wenxia Ma7, Jie Li7, Wenjuan Wang7,8, Liang Wang2,3,4, Brynn N Akerberg9, Jiqian Xu10,11, Islam Osman2, Zeqi Zheng3,4, Wang Wang10,11, Quansheng Du12, William T Pu9, Meixiang Xiang6, Weiqin Chen5, Huabo Su2,7, Wei Zhang13, Jiliang Zhou14.   

Abstract

The Hippo signaling effector, TEAD1 plays an essential role in cardiovascular development. However, a role for TEAD1 in postmitotic cardiomyocytes (CMs) remains incompletely understood. Herein we reported that TEAD1 is required for postmitotic CM survival. We found that adult mice with ubiquitous or CM-specific loss of Tead1 present with a rapid lethality due to an acute-onset dilated cardiomyopathy. Surprisingly, deletion of Tead1 activated the necroptotic pathway and induced massive cardiomyocyte necroptosis, but not apoptosis. In contrast to apoptosis, necroptosis is a pro-inflammatory form of cell death and consistent with this, dramatically higher levels of markers of activated macrophages and pro-inflammatory cytokines were observed in the hearts of Tead1 knockout mice. Blocking necroptosis by administration of necrostatin-1 rescued Tead1 deletion-induced heart failure. Mechanistically, genome-wide transcriptome and ChIP-seq analysis revealed that in adult hearts, Tead1 directly activates a large set of nuclear DNA-encoded mitochondrial genes required for assembly of the electron transfer complex and the production of ATP. Loss of Tead1 expression in adult CMs increased mitochondrial reactive oxygen species, disrupted the structure of mitochondria, reduced complex I-IV driven oxygen consumption and ATP levels, resulting in the activation of necroptosis. This study identifies an unexpected paradigm in which TEAD1 is essential for postmitotic CM survival by maintaining the expression of nuclear DNA-encoded mitochondrial genes required for ATP synthesis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33469230      PMCID: PMC8257617          DOI: 10.1038/s41418-020-00732-5

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  46 in total

Review 1.  Programmed necrosis in heart disease: Molecular mechanisms and clinical implications.

Authors:  Hong Zhu; Aijun Sun
Journal:  J Mol Cell Cardiol       Date:  2018-02-06       Impact factor: 5.000

Review 2.  Classification, Epidemiology, and Global Burden of Cardiomyopathies.

Authors:  William J McKenna; Barry J Maron; Gaetano Thiene
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 3.  Necroptotic cell death in failing heart: relevance and proposed mechanisms.

Authors:  Adriana Adameova; Eva Goncalvesova; Adrian Szobi; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 4.  Cell death in the myocardium: my heart won't go on.

Authors:  Amabel M Orogo; Åsa B Gustafsson
Journal:  IUBMB Life       Date:  2013-07-03       Impact factor: 3.885

Review 5.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

Review 6.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

Review 7.  Mitochondrial involvement in myocyte death and heart failure.

Authors:  Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 8.  Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.

Authors:  Deborah E Meyers; Haseeb Ilias Basha; Mary Kay Koenig
Journal:  Tex Heart Inst J       Date:  2013

9.  Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway.

Authors:  Pingjun Zhu; Shunying Hu; Qinhua Jin; Dandan Li; Feng Tian; Sam Toan; Yang Li; Hao Zhou; Yundai Chen
Journal:  Redox Biol       Date:  2018-03-01       Impact factor: 11.799

10.  NDUFAB1 confers cardio-protection by enhancing mitochondrial bioenergetics through coordination of respiratory complex and supercomplex assembly.

Authors:  Tingting Hou; Rufeng Zhang; Chongshu Jian; Wanqiu Ding; Yanru Wang; Shukuan Ling; Qi Ma; Xinli Hu; Heping Cheng; Xianhua Wang
Journal:  Cell Res       Date:  2019-07-31       Impact factor: 25.617

View more
  7 in total

1.  Exosomes Derived from Mesenchymal Stem Cells Ameliorate the Progression of Atherosclerosis in ApoE-/- Mice via FENDRR.

Authors:  Nan Zhang; Yuxin Luo; Huaping Zhang; Feng Zhang; Xiang Gao; Jiawei Shao
Journal:  Cardiovasc Toxicol       Date:  2022-03-27       Impact factor: 3.231

2.  YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation.

Authors:  Islam Osman; Kunzhe Dong; Xiuhua Kang; Luyi Yu; Fei Xu; Abu Shufian Ishtiaq Ahmed; Xiangqin He; Jian Shen; Guoqing Hu; Wei Zhang; Jiliang Zhou
Journal:  J Mol Cell Cardiol       Date:  2021-03-19       Impact factor: 5.763

3.  Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming.

Authors:  Vivek P Singh; Jaya P Pinnamaneni; Aarthi Pugazenthi; Deepthi Sanagasetti; Megumi Mathison; James F Martin; Jianchang Yang; Todd K Rosengart
Journal:  J Am Heart Assoc       Date:  2021-12-10       Impact factor: 6.106

4.  Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1-RIPK3-Dependent Pathway in Mice.

Authors:  Penglong Wu; Mingqi Cai; Jinbao Liu; Xuejun Wang
Journal:  Front Cardiovasc Med       Date:  2021-09-16

5.  Transcriptomic Analysis of Dysregulated Genes of the nDNA-mtDNA Axis in a Mouse Model of Dilated Cardiomyopathy.

Authors:  Mark Ziemann; Wei Wu; Xiu-Ling Deng; Xiao-Jun Du
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

Review 6.  The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response.

Authors:  Ancheng Zheng; Qishan Chen; Li Zhang
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

7.  Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice.

Authors:  Wei Wu; Mark Ziemann; Kevin Huynh; Gang She; Zheng-Da Pang; Yi Zhang; Thy Duong; Helen Kiriazis; Tian-Tian Pu; Ru-Yue Bai; Jing-Jing Li; Yu Zhang; Ming-Xia Chen; Junichi Sadoshima; Xiu-Ling Deng; Peter J Meikle; Xiao-Jun Du
Journal:  Theranostics       Date:  2021-08-21       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.